Farah recently choreographed a song for Salman Khan’s film Sikandar. The track, titled Zohra Jabeen, featured Salman and Rashmika Mandanna and quickly became a fan favourite thanks to its catchy ...

Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie ABBV revealed 20 unusual trades. Delving into the details, we found 45% of traders were ...

Looking at the universe of stocks we cover at Dividend Channel, on 4/15/25, Buckle, Inc. (Symbol: BKE), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend ...

Tony Khan is an American businessman and entrepreneur who has become one of the most important figures in pro wrestling history as the owner and CEO of All Elite Wrestling. Founding the company ...

The Investment Committee give you their top stocks to watch for the second half. U.S. fires head of military base in Greenland after JD Vance visit ‘for undermining chain of command’ The Best ...

Sunny Deol and Shah Rukh Khan’s long-standing cold war following the 1993 release of Darr is now officially water under the bridge. While the two didn’t see eye to eye for decades after their ...

In the latest comedian Kunal Kamra has turned down an offer from the Salman Khan-hosted show. But, he is not alone. From Rajesh Khanna to Kamra and even Yo Yo Honey Singh, these celebs rejected ...

AbbVie stock outperformed S&P 500 with a +16% to 9.41% return since November 2023, despite Humira revenue declining 38% to $8.99 billion. Immunology drugs Skyrizi and Rinvoq grew over 50% year ...

Vicky Kaushal's historical drama Chhaava has surpassed Shah Rukh Khan's Jawan in India net collections, becoming the third biggest hit in Hindi cinema with Rs 583.3 crore. Its Telugu release added ...

Salman Khan's 'Sikandar' faced a disappointing run after its release. The film's opening day collections were lower than expected. 'Sikandar' showed initial growth due to the Eid holiday.

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target of $240.00. The company’s shares closed yesterday ...

The European Commission (EC) has granted marketing authorisation for AbbVie's once-a-day treatment Rinvoq (upadacitinib) 15mg for adults with giant cell arteritis (GCA). It is the first and only ...